These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 17875341)

  • 21. Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients.
    Guadagni F; Ferroni P; Basili S; Facciolo F; Carlini S; Crecco M; Martini F; Spila A; D'Alessandro R; Aloe S; Cerasoli V; Del Monte G; Mariotti S; Mineo TC; Roselli M
    Lung Cancer; 2004 Jun; 44(3):303-10. PubMed ID: 15140543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
    Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum endostatin levels in patients with lung carcinoma.
    Swidzińska E; Ossolińska M; Naumnik W; Trojan S; Chyczewska E
    Rocz Akad Med Bialymst; 2005; 50():197-200. PubMed ID: 16358965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of plasma tumour necrosis factor-alpha and transforming growth factor-beta1 as predictors of survival and treatment outcome in advanced non-small cell lung carcinoma.
    Kumar S; Guleria R; Mohan A; Singh V; Ali A; Bharti AC; Das BC
    Biomarkers; 2010 Aug; 15(5):446-53. PubMed ID: 20486867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer.
    Moon YW; Choi SH; Kim YT; Sohn JH; Chang J; Kim SK; Park MS; Chung KY; Lee HJ; Kim JH
    Cancer; 2007 May; 109(9):1829-35. PubMed ID: 17366594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of sFas and sFasL during chemotherapy of lung cancer.
    Naumnik W; Izycki T; Ossolinska M; Chyczewska E
    Exp Oncol; 2007 Jun; 29(2):132-6. PubMed ID: 17704746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
    Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE
    J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of IGF-I and IGF-II in patients with lung cancer during chemotherapy.
    Izycki T; Chyczewska E; Naumnik W; Talalaj J; Panek B; Ossolinska M
    Exp Oncol; 2004 Dec; 26(4):316-9. PubMed ID: 15627066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteopontin as a marker of weight loss in lung cancer.
    Karadag F; Gulen ST; Karul AB; Kilicarslan N; Ceylan E; Kuman NK; Cildag O
    Scand J Clin Lab Invest; 2011 Dec; 71(8):690-4. PubMed ID: 22017168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The detection of quantitative serum p53 protein in lung cancer.
    Sen E; Gönüllü U; Akar N
    Tuberk Toraks; 2005; 53(3):231-7. PubMed ID: 16258881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma.
    Shinohara ET; Gonzalez A; Massion PP; Chen H; Li M; Freyer AS; Olson SJ; Andersen JJ; Shyr Y; Carbone DP; Johnson DH; Hallahan DE; Lu B
    Cancer; 2005 Apr; 103(8):1685-92. PubMed ID: 15742356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy.
    Gautschi O; Bigosch C; Huegli B; Jermann M; Marx A; Chassé E; Ratschiller D; Weder W; Joerger M; Betticher DC; Stahel RA; Ziegler A
    J Clin Oncol; 2004 Oct; 22(20):4157-64. PubMed ID: 15483026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between N-linked oligosaccharide chains of human serum immunoglobulin G and serum tumor markers with non-small cell lung cancer progression.
    Kanoh Y; Ohara T; Mashiko T; Abe T; Masuda N; Akahoshi T
    Anticancer Res; 2006; 26(6B):4293-7. PubMed ID: 17201147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer.
    Huang CL; Liu D; Nakano J; Yokomise H; Ueno M; Kadota K; Wada H
    Clin Cancer Res; 2007 Dec; 13(23):6938-46. PubMed ID: 18056168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokeratin 8 and 18 fragments measured in serum and their relation to survival in patients with non-small cell lung cancer.
    Bergqvist M; Brattström D; Hesselius P; Wiklund B; Silen A; Wagenius G; Brodin O
    Anticancer Res; 1999; 19(3A):1833-6. PubMed ID: 10470123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum angiopoietin-1 as a prognostic marker in resected early stage lung cancer.
    Park JH; Choi H; Kim YB; Kim YS; Sheen SS; Choi JH; Lee HL; Lee KS; Chung WY; Lee S; Park KJ; Hwang SC; Lee KB; Park KJ
    Lung Cancer; 2009 Dec; 66(3):359-64. PubMed ID: 19339077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mental state as a possible independent prognostic variable for survival in patients with advanced lung carcinoma.
    Nakahara Y; Mochizuki Y; Miyamoto Y; Tanaka A; Kawamura T; Sasaki S; Nakahara Y; Katsura Y
    Cancer; 2002 Jun; 94(11):3006-15. PubMed ID: 12115391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
    Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V
    Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic value of serum epidermal growth factor receptor level in patients with non-small cell lung cancer.
    Ciledağ A; Kaya A; Yetkin O; Poyraz B; Savaş I; Numanoğlu N; Savaş H
    Tuberk Toraks; 2008; 56(4):390-5. PubMed ID: 19123074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of alpha-1 antitrypsin (alpha1-AT) and neopterin serum levels in the evaluation of non-small cell lung and prostate cancer patients.
    El-Akawi ZJ; Abu-Awad AM; Sharara AM; Khader Y
    Neuro Endocrinol Lett; 2010; 31(1):113-6. PubMed ID: 20150872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.